My Quote Request
No products added yet
6505-01-037-9356
20 Products
NEOSAR
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505010379356
NSN
6505-01-037-9356
NEOSAR
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505010379356
NSN
6505-01-037-9356
MFG
ADRIA LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ANHYDROUS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOPHOSPHAMIDE FOR INJECTION USP 500MG VIAL 12S BX
III THERAPEUTIC EQUIVALENT: NEOSAR BY ABBOTT; CYTOXAN BY BRISTOL LABS
III WARNING AND CAUTION STATEMENTS: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL WITH NOT LESS THAN 30 ML CAPACITY
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00074-5626-01
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505010379356
NSN
6505-01-037-9356
NDC00074-5626-01
CYCLOPHOSPHAMIDE FOR INJECTION,USP
NSN, MFG P/N
6505010379356
NSN
6505-01-037-9356
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS ANHYDROUS CYCLOPHOSPHAMIDE ACTIVE INGREDIENT
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CYCLOPHOSPHAMIDE FOR INJECTION USP 500MG VIAL 12S BX
III THERAPEUTIC EQUIVALENT: NEOSAR BY ABBOTT; CYTOXAN BY BRISTOL LABS
III WARNING AND CAUTION STATEMENTS: CHEMOTHERAPEUTIC AGENT; HANDLE WITH CARE
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: VIAL WITH NOT LESS THAN 30 ML CAPACITY
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
D/C SCHEDULE MC5-1-7T
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505010381249
NSN
6505-01-038-1249
D/C SCHEDULE MC5-1-7T
ALBUMIN HUMAN,USP
NSN, MFG P/N
6505010381249
NSN
6505-01-038-1249
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
SPECIAL FEATURES: CONCENTRATE,SALT-POOR;ACTIVE INGREDIENTS: 25 PCT PER 50ML OF FORMULA
Related Searches:
NDC00015-7988-64
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505010384540
NSN
6505-01-038-4540
NDC00015-7988-64
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505010384540
NSN
6505-01-038-4540
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 GRAMS AMPICILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN FOR ORAL SUSPENSION USP 125MG/5ML 200ML BT
III PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 125 MG AMPICILLIN PER 5 ML WHEN RECONSTITUTED TO 200 ML; PALATABLE; CHILD RESISTANT SAFETY CLOSURE
Related Searches:
NDC55370-0882-40
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505010384540
NSN
6505-01-038-4540
NDC55370-0882-40
AMPICILLIN FOR ORAL SUSPENSION,USP
NSN, MFG P/N
6505010384540
NSN
6505-01-038-4540
MFG
MOVA PHARMACEUTICAL CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 GRAMS AMPICILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMPICILLIN FOR ORAL SUSPENSION USP 125MG/5ML 200ML BT
III PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 125 MG AMPICILLIN PER 5 ML WHEN RECONSTITUTED TO 200 ML; PALATABLE; CHILD RESISTANT SAFETY CLOSURE
Related Searches:
967-10
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
967-10
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN PRESERVED
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
96710
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
96710
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN PRESERVED
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00467-1067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
NDC00467-1067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN PRESERVED
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
NDC00517-2110-01
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
NDC00517-2110-01
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505010384542
NSN
6505-01-038-4542
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIEQUIVALENTS POTASSIUM CHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: PARABEN PRESERVED
THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
Related Searches:
318
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010385071
NSN
6505-01-038-5071
318
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010385071
NSN
6505-01-038-5071
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 97.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 OUNCES
PRIMARY CONTAINER TYPE: KIT
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: DISPOSABLE VINYL BAG W/8 FEET OF TUBING,PLASTIC SPRING CLAMP AND RIGIDCLAMP,RED-SNAP CAP
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 24
Related Searches:
SOL-O-PAKE
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010385071
NSN
6505-01-038-5071
SOL-O-PAKE
BARIUM SULFATE FOR SUSPENSION,USP
NSN, MFG P/N
6505010385071
NSN
6505-01-038-5071
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 97.000 PERCENTAGE, W/W BARIUM SULFATE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 OUNCES
PRIMARY CONTAINER TYPE: KIT
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: DISPOSABLE VINYL BAG W/8 FEET OF TUBING,PLASTIC SPRING CLAMP AND RIGIDCLAMP,RED-SNAP CAP
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 24
Related Searches:
79818
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
79818
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 32.500 MILLIGRAMS PHENOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 LOZENGES
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 216 CHERRY FLAVORED LOZENGES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
CHLORASEPTIC
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
CHLORASEPTIC
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 32.500 MILLIGRAMS PHENOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 LOZENGES
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 216 CHERRY FLAVORED LOZENGES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
CHLORASEPTIC LOZENGES
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
CHLORASEPTIC LOZENGES
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 32.500 MILLIGRAMS PHENOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 LOZENGES
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 216 CHERRY FLAVORED LOZENGES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00149-0798-18
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
NDC00149-0798-18
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 32.500 MILLIGRAMS PHENOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 LOZENGES
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 216 CHERRY FLAVORED LOZENGES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC23900-7981-80
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
NDC23900-7981-80
PHENOL AND SODIUM PHENOLATE LOZENGES
NSN, MFG P/N
6505010386845
NSN
6505-01-038-6845
MFG
RICHARDSON-VICKS INC VICKS HEALTH CARE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 32.500 MILLIGRAMS PHENOL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 LOZENGES
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 216 CHERRY FLAVORED LOZENGES PER PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC53489-0506-01
TOLMETIN SODIUM TABLETS,USP
NSN, MFG P/N
6505010387460
NSN
6505-01-038-7460
NDC53489-0506-01
TOLMETIN SODIUM TABLETS,USP
NSN, MFG P/N
6505010387460
NSN
6505-01-038-7460
MFG
MUTUAL PHARMACEUTICAL COMPANY INC. DBA URL PHARMA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS TOLMETIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOLMETIN SODIUM TABLETS USP EQUIVALENT 10 200MG OF TOLMETIN 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC20993-0001-01
HEMOSTATIC TOPICAL
NSN, MFG P/N
6505010387669
NSN
6505-01-038-7669
MFG
DEPT OF HEALTH EDUCATION AND WELFARE FOOD AND DRUG ADMINISTRATION BUREAU OF DRUGS REGISTRATION SECTION
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: ABSORBABLE,DRY,FIBROUS,STERILE,WATER INSOLUBLE,PARTIAL HYDROCHLORIC ACID SALT OF PURIFIED BOVINE CORIUM COLLAGEN,1 GM JAR
Related Searches:
NDC00115-2622-01
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505010392808
NSN
6505-01-039-2808
NDC00115-2622-01
TERBUTALINE SULFATE TABLETS,USP
NSN, MFG P/N
6505010392808
NSN
6505-01-039-2808
MFG
GREAT SOUTH TIMBER INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TERBUTALINE SULFATE TABLETS USP 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 5.000 MILLIGRAMS TERBUTALINE SULFATE ACTIVE INGREDIENT
Related Searches:
0014-1011-51
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505010393389
NSN
6505-01-039-3389
0014-1011-51
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505010393389
NSN
6505-01-039-3389
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
